Vaddi Krishna, CEO of Prelude Therapeutics Inc ($PRLD), bought shares on the open market five times in the last year, totaling about $512,000. His most recent purchase occurred on March 25, 2025. Among nearly 5,000 insiders, his purchases rank 802nd for total value, below the average of 1.5 million per buyer and 3.3 transactions. He reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Prelude Therapeutics Inc | $PRLD | Vaddi Krishna | CEO | A | Employee Stock Option (right to buy) | 837000 | $0.00 | 837,000.0000 | 76,132,337 | 9999.99% | 1.10% |
| March 25, 2025 | Prelude Therapeutics Inc | $PRLD | Vaddi Krishna | CEO | P | Common Stock | 675000 | $0.69 | 3,669,054.0000 | 75,805,840 | 22.54% | 0.89% |
| March 21, 2025 | Prelude Therapeutics Inc | $PRLD | Vaddi Krishna | CEO | P | Common Stock | 15000 | $0.73 | 2,994,054.0000 | 75,805,840 | 0.50% | 0.02% |
| March 20, 2025 | Prelude Therapeutics Inc | $PRLD | Vaddi Krishna | CEO | P | Common Stock | 5416 | $0.73 | 2,979,054.0000 | 75,805,840 | 0.18% | 0.01% |
| March 17, 2025 | Prelude Therapeutics Inc | $PRLD | Vaddi Krishna | CEO | P | Common Stock | 9106 | $0.75 | 2,973,638.0000 | 75,805,840 | 0.31% | 0.01% |
| March 14, 2025 | Prelude Therapeutics Inc | $PRLD | Vaddi Krishna | CEO | P | Common Stock | 29999 | $0.75 | 2,964,532.0000 | 75,805,840 | 1.02% | 0.04% |
| March 13, 2025 | Prelude Therapeutics Inc | $PRLD | Vaddi Krishna | CEO | P | Common Stock | 50000 | $0.72 | 2,934,533.0000 | 75,805,840 | 1.73% | 0.07% |
| March 12, 2025 | Prelude Therapeutics Inc | $PRLD | Vaddi Krishna | CEO | P | Common Stock | 47500 | $0.71 | 2,884,533.0000 | 75,805,840 | 1.67% | 0.06% |
| Feb. 4, 2025 | Prelude Therapeutics Inc | $PRLD | Vaddi Krishna | CEO | A | Employee Stock Option (right to buy) | 496000 | $0.00 | 496,000.0000 | 75,805,840 | 9999.99% | 0.65% |
| Dec. 31, 2024 | Prelude Therapeutics Inc | $PRLD | Vaddi Krishna | CEO | P | Common Stock | 5000 | $1.21 | 2,837,033.0000 | 75,855,949 | 0.18% | 0.01% |
| Dec. 30, 2024 | Prelude Therapeutics Inc | $PRLD | Vaddi Krishna | CEO | P | Common Stock | 10000 | $1.20 | 2,832,043.0000 | 75,855,949 | 0.35% | 0.01% |
| Dec. 18, 2024 | Prelude Therapeutics Inc | $PRLD | Vaddi Krishna | CEO | P | Common Stock | 100000 | $0.93 | 2,822,043.0000 | 75,855,949 | 3.67% | 0.13% |
| Dec. 19, 2024 | Prelude Therapeutics Inc | $PRLD | Vaddi Krishna | CEO | P | Common Stock | 6888 | $0.89 | 2,822,043.0000 | 75,855,949 | 0.24% | 0.01% |
| March 1, 2024 | Prelude Therapeutics Inc | $PRLD | Vaddi Krishna | CEO | A | Employee Stock Option (right to buy) | 425000 | $0.00 | 425,000.0000 | 60,357,052 | 9999.99% | 0.70% |